ESTIV2026 aims to be a premier international platform bringing together scientists and professionals advancing in vitro toxicology and innovative New Approach Methodologies (NAMs). The congress welcomes participants from academia, industry, biotech, pharmaceuticals, chemicals, medical devices, CROs, regulatory authorities, and all sectors committed to the future of non-animal science.

Held in the historic and strategically located city of Maastricht—where bridges connect cultures, countries, and ideas—ESTIV2026 will showcase cutting-edge advances in mechanistic toxicology, 3D and microphysiological systems, computational approaches, integrated testing strategies, and regulatory science. The meeting will highlight how collaborative innovation can bridge fundamental research with real-world application, regulatory acceptance, and societal impact.

Why Attend

• Connect with leading scientists, innovators, and regulators shaping the future of in vitro and NAM-based toxicology
• Explore scientific and technological advances in 3D models, organ-on-chip systems, computational toxicology, PBPK/TK modeling, read-across, and integrated assessment strategies
• Gain insights into current challenges, opportunities, and the regulatory landscape for adopting NAMs across sectors
• Engage in multi-stakeholder discussions on how to bridge science, policy, and implementation
• Experience Maastricht’s vibrant international environment with rich networking opportunities